In our latest newsletter, we discussed our commitment to understanding the mechanisms of action and measuring key parameters and biomarkers. This approach allows us to quantify the concrete impact on motor and cognitive performance, with observable effects shortly after initial intake. In…
Did you know that L-dopa was first discovered by Markus Guggenheim in 1913, and that he isolated it from the Vicia faba plant? Furthermore, did you know that numerous scientific studies from expert teams worldwide have demonstrated that the Vicia…
In this new newsletter, we will delve deeper into our quest to make things measurable and thus quantify the improvements following the use of AtremoPlus. “Advances in medicine often result from the ability to accurately measure biological phenomena (…). Biomarkers…
In this new edition of our newsletter, we will address a fundamental topic: Energy. While maintaining and cultivating energy can be challenging in a demanding and stressful life, it becomes even more delicate for individuals with Parkinson’s disease. Dopamine is…